Associate Professor David Sullivan

Clinical Associate Professor
NHMRC Clinical Trials Centre, Sydney Medical School

Telephone +61 2 9515 8832
Fax +61 2 9515 7931

Map

Research interests

Cardiovascular disease prevention, Nutrition, Inherited disorders.

Selected grants

2012

  • Approaches to inhibit SAA-induced endothelial dysfunction and atherosclerosis; Witting P, Freedman B, Geczy C, Skilton M, Sullivan D; Heart Foundation of Australia/Grants-in-Aid.

2010

  • Unlocking genetic factors predicting type 2 diabetes complications for clinical practice: The Field Study; Keech A, Best J, Jenkins A, Sullivan D, Twigg S; National Health and Medical Research Council (NHMRC)/Project Grants.

2009

  • Innovations for better cardiovascular prevention in primary care; MacMahon S, Neal B, Patel A, Sullivan D, Harris M; National Health and Medical Research Council (NHMRC)/Development Grants.

2005

  • Mechanisms for ageing changes in the hepatic sinusoid; Le Couteur D, McKinnon K, Fraser R, Muller M, Cogger V, Harris M, Sullivan D; National Health and Medical Research Council (NHMRC)/Project Grants.
  • How is lipoprotein disposition influenced by fenestrae in the hepatic sinusoidal endothelium?; Le Couteur D, McKinnon K, Fraser R, Cogger V, Sullivan D; National Health and Medical Research Council (NHMRC)/Project Grants.

2003

  • The effect of hepatic pseudocapillarisation of old age on the disposition of chylomicron remnants and chylomicrons; Le Couteur D, Sullivan D, Fraser R, McLean A; National Health and Medical Research Council (NHMRC)/Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Book Chapters

  • Le Couteur, D., Cogger, V., Hilmer, S., Muller, M., Harris, M., Sullivan, D., McLean, A., Fraser, R. (2006). Aging, atheroscleroisis and the liver sieve. In Clarke, Leon V (Eds.), New research on atherosclerosis, (pp. 19-44). New York: Nova Science Publishers.
  • Field, M., Burnett, L., Sullivan, D., Stewart, P. (2006). Clinical biochemistry and metabolism. In NA Boon, NR Colledge, BR Walker, JAA Hunter (Eds.), Davidson's Principles & Practice of Medicine, (pp. 419-454). Edinburgh: Churchill Livingstone.
  • Field, M., Burnett, L., Sullivan, D., Stewart, P. (2005). Biochemical Disorders. In N Boon, N Colledge, B Walker, J Hunter (Eds.), Davidson's Principles and Practice of Medicine (20 Ed.), (pp. 1-2). United Kingdom: Elsevier.
  • Field, M., Burnett, L., Sullivan, D., Stewart, P. (2005). Clinical biochemistry and metabolism. In Nicholas A. Boon, Nicki R. Colledge, Brian R. Walker and John Hunter (Eds.), Davidson's Principles and Practice of Medicine, (pp. 419-454). Churchill Livingstone.
  • Lai, N., Lyons-Wall, P., Samman, S., Sullivan, D. (2004). Intake of Selected Phytochemicals and Prevention of Coronary Heart Disease: Practical Implications. In R. Nath, M. Khullar and P. Singal (Eds.), Antioxidants and Cardiovascular Disease, (pp. 194-202). New Delhi, India: Narosa Publishing House.

Journals

  • Stroes, E., Colquhoun, D., Sullivan, D., Civeira, F., Rosenson, R., Watts, G., Bruckert, E., Cho, L., Dent, R., Knusel, B., et al (2014). Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients with Statin Intolerance: The GAUSS-2 Randomized, Placebo-controlled Phase 3 Clinical Trial of Evolocumab. Journal of the American College of Cardiology, 63(23), 2541-2548. [More Information]
  • White, H., Tonkin, A., Simes, R., Stewart, R., Mann, K., Thompson, P., Colquhoun, D., West, M., Nestel, P., Sullivan, D., Keech, A., et al (2014). Association of Contemporary Sensitive Troponin I Levels at Baseline and Change at 1 Year With Long - Term Coronary Events Following Myocardial Infarction or Unstable Angina. Journal of the American College of Cardiology, 63(4), 345-354. [More Information]
  • Cho, L., Rocco, M., Colquhoun, D., Sullivan, D., Rosenson, R., Dent, R., Xue, A., Scott, R., Wasserman, S., Stroes, E. (2014). Design and rationale of the GAUSS-2 study trial: a double-blind, ezetimibe-controlled phase 3 study of the efficacy and tolerability of evolocumab (AMG 145) in subjects with hypercholesterolemia who are intolerant of statin therapy. Clinical cardiology, 37(3), 131-139. [More Information]
  • Hinchcliffe, M., Le, H., Fimmel, A., Molloy, L., Freeman, L., Sullivan, D., Trent, R. (2014). Diagnostic validation of a familial hypercholesterolaemia cohort provides a model for using targeted next generation DNA sequencing in the clinical setting. Pathology, 46(1), 60-68. [More Information]
  • Watts, G., Gidding, S., Wierzbicki, A., Toth, P., Rodrigo, A., Brown, W., Bruckert, E., Defesche, J., Lin, K., Livingston, M., Sullivan, D., et al (2014). Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. International Journal of Cardiology, 171(3), 309-325. [More Information]
  • Watts, G., Gidding, S., Wierzbicki, A., Toth, P., Alonso, R., Brown, W., Bruckert, E., Defesche, J., Lin, K., Livingston, M., Sullivan, D., et al (2014). Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation. Journal of Clinical Lipidology, 8(2), 148-172. [More Information]
  • White, H., Simes, R., Stewart, R., Blankenberg, S., Barnes, E., Marschner, C., Thompson, P., West, M., Zeller, T., Colquhoun, D., Keech, A., Sullivan, D., et al (2013). Changes in lipoprotein-associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study. Journal of the American Heart Association, 2(5), 1-12. [More Information]
  • Hoyos, C., Sullivan, D., Liu, P. (2013). Effect of CPAP on the metabolic syndrome: a randomised sham-controlled study. Thorax, 68(6), 588-589. [More Information]
  • Martin, A., Coakley, J., Forbes, D., Sullivan, D., Watts, G. (2013). Familial hypercholesterolaemia in children and adolescents: A new paediatric model of care. Journal of Paediatrics and Child Health, 49(4), E263-E272. [More Information]
  • Boekholdt, S., Arsenault, B., Hovingh, G., Mora, S., Pedersen, T., LaRosa, J., Welch, K., Amarenco, P., DeMicco, D., Tonkin, A., Sullivan, D., Kirby, A., et al (2013). Levels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients: A Meta-Analysis. Circulation, 128(14), 1504-1512. [More Information]
  • Nestel, P., Barnes, E., Tonkin, A., Simes, R., Fournier, M., White, H., Colquhoun, D., Blankenberg, S., Sullivan, D. (2013). Plasma Lipoprotein(a) Concentration Predicts Future Coronary and Cardiovascular Events in Patients With Stable Coronary Heart Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 33(12), 2902-2908. [More Information]
  • Chan, K., O'Connell, R., Sullivan, D., Hoffmann, L., Rajamani, K., Whiting, M., Donoghoe, M., Vanhala, M., Hamer, A., Yu, B., Stocker, R., Ng, M., Keech, A. (2013). Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the fenofibrate intervention and event lowering in diabetes (field) study. Diabetologia: clinical and experimental diabetes and metabolism, 56(4), 724-736. [More Information]
  • Hankey, G., Anderson, N., Ting, R., Veillard, A., Romo, M., Wosik, M., Sullivan, D., O'Connell, R., Hunt, D., Keech, A. (2013). Rates and predictors of risk of stroke and its subtypes in diabetes: A prospective observational study. Journal of Neurology, Neurosurgery and Psychiatry, 84(3), 281-287. [More Information]
  • Lewis, B., Sullivan, D., Watts, G. (2013). Thought for food: Clinical evidence for the dietary prevention strategy in cardiovascular disease. International Journal of Evidence-Based Healthcare (online), 11(4), 330-336. [More Information]
  • Watts, G., Sullivan, D., van Bockxmeer, F., Poplawski, N., Hamilton-Craig, I., Clifton, P., O'Brien, R., Bishop, W., George, P., Semsarian, C., et al (2012). A New Model of Care for Familial Hypercholesterolaemia: What is the Role of Cardiology? Heart, Lung and Circulation, 21(9), 543-550. [More Information]
  • McEwen, B., Phillips, C., Morel-Kopp, M., Yee, B., Sullivan, D., Ward, C., Tofler, G., Grunstein, R. (2012). Diurnal changes and levels of fibrin generation are not altered by continuous positive airway pressure (CPAP) in obstructive sleep apnoea (OSA). Journal of Thrombosis and Haemostasis, 108(4), 701-709. [More Information]
  • Sullivan, D., Olsson, A., Scott, R., Kim, J., Xue, A., Gebski, V., Wasserman, S., Stein, E. (2012). Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial. JAMA, 308(23), 2497-2506. [More Information]
  • Phillips, C., McEwen, B., Morel-Kopp, M., Yee, B., Sullivan, D., Ward, C., Tofler, G., Grunstein, R. (2012). Effects of continuous positive airway pressure on coagulability in obstructive sleep apnoea: a randomised, placebo-controlled crossover study. Thorax, 67(7), 639-644. [More Information]
  • Nik Tavakoli, N., Harris, A., Sullivan, D., Hambly, B., Bao, B. (2012). Interferon-g deficiency reduces neointimal formation in a model of endoluminal endothelial injury combined with atherogenic diet. International Journal of Molecular Medicine, 30(3), 545-552. [More Information]
  • Sullivan, D., Hamilton-Craig, I., van Bockxmeer, F., Watts, G. (2012). INTERIM Guidelines for the Diagnosis and Management of Familial Hypercholesterolaemia. Heart, Lung and Circulation, 21(3), 159-162. [More Information]
  • Ong, K., Rye, K., O'Connell, R., Jenkins, A., Brown, C., Xu, A., Sullivan, D., Barter, P., Keech, A. (2012). Long-Term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-Binding Protein 4 in Subjects with Type 2 Diabetes. Journal of Clinical Endocrinology and Metabolism, 97(12), 4701-4708. [More Information]
  • Kotwal, S., Jun, M., Sullivan, D., Perkovic, V., Neal, B. (2012). Omega 3 Fatty Acids and Cardiovascular Outcomes: Systematic Review and Meta-Analysis. Circulation. Cardiovascular Quality and Outcomes, 5(6), 808-818. [More Information]
  • Herrmann, M., Whiting, M., Veillard, A., Ehnholm, C., Sullivan, D., Keech, A. (2012). Plasma homocysteine and the risk of venous thromboembolism: Insights from the FIELD study. Clinical Chemistry and Laboratory Medicine, 50(12), 2213-2219. [More Information]
  • Sullivan, D., Lewis, B. (2011). A classification of lipoprotein disorders: Implications for clinical management. Clinical Lipidology, 6(3), 327-338.
  • Sullivan, D., Forder, P., Simes, R., Whiting, M., Kritharides, L., Merrifield, A., Donoghoe, M., Colman, P., Neil, G., Haapamäki, H., Keech, A. (2011). Associations between the use of metformin, sulphonylureas, or diet alone and cardiovascular outcomes in 6005 patients with type 2 diabetes in the FIELD study. Diabetes Research and Clinical Practice, 94(2), 284-290. [More Information]
  • Phillips, C., Yee, B., Marshall, N., Liu, P., Sullivan, D., Grunstein, R. (2011). Continuous Positive Airway Pressure Reduces Postprandial Lipidemia in Obstructive Sleep Apnea. A Randomised, Placebo Controlled Crossover Trial. American Journal of Respiratory and Critical Care Medicine, 184(3), 355-361. [More Information]
  • Watts, G., Sullivan, D., Poplawski, N., van Bockxmeer, F., Hamilton-Craig, I., Clifton, P., O'Brien, R., Bishop, W., George, P., Barter, P., Freeman, L., Krass, I., Trent, R., et al (2011). Familial hypercholesterolaemia: A model of care for Australasia. Atherosclerosis Supplements, 12, 221-263. [More Information]
  • Perera, N., Lewis, B., Tran, H., Fietz, M., Sullivan, D. (2011). Refsum's Disease-Use of the Intestinal Lipase Inhibitor, Orlistat, as a Novel Therapeutic Approach to a Complex Disorder. Journal of Obesity, 2011 (482021). [More Information]
  • Simes, R., Voysey, M., O'Connell, R., Glasziou, P., Best, J., Scott, R., Pardy, C., Byth Wilson, K., Sullivan, D., Ehnholm, C., Keech, A. (2010). A novel method to adjust efficacy estimates for uptake of other active treatments in long-term clinical trials. PLoS One, 5(1), e8580-1-e8580-10. [More Information]
  • Taskinen, M., Barter, P., Ehnholm, C., Sullivan, D., Mann, K., Simes, R., Best, J., Hamwood, S., Keech, A. (2010). Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes. Diabetologia: clinical and experimental diabetes and metabolism, 53(9), 1846-1855. [More Information]
  • Perera, N., Burns, J., Perera, R., Lewis, B., Sullivan, D. (2010). Adjustment of direct high-density lipoprotein cholesterol measurements according to intercurrent triglyceride corrects for interference by triglyceride-rich lipoproteins. Journal of Clinical Lipidology, 4(4), 305-309. [More Information]
  • Al-Sarraf, A., Al-Ghofaili, K., Sullivan, D., Wasan, K., Hegele, R., Frohlich, J. (2010). Complete Apo AI deficiency in an Iraqi Mandaean family: case studies and review of the literature. Journal of Clinical Lipidology, 4(5), 420-426. [More Information]
  • Arya, F., Egger, S., Colquhoun, D., Sullivan, D., Pal, S., Egger, G. (2010). Differences in postprandial inflammatory responses to a 'modern' v. traditional meat meal: a preliminary study. British Journal of Nutrition, 104(5), 724-728. [More Information]
  • Webster, R., Webster, R., Li, S., Li, S., Sullivan, D., Sullivan, D., Su, S., Su, S., Jayne, K., Jayne, K., Neal, B., Neal, B. (2010). Effects Of Internet-Based Tailored Advice on the Use of Cholesterol-Lowering Interventions: A Randomized Controlled Trial. Journal of Medical Internet Research, 12(3), 1-13. [More Information]
  • Puranik, R., Puranik, R., Fox, O., Fox, O., Sullivan, D., Sullivan, D., Duflou, J., Duflou, J., Bao, B., Bao, B. (2010). Inflammatory characteristics of premature coronary artery disease. International Journal of Cardiology, 145(2), 288-290. [More Information]
  • Lewis, B., Watts, G., Sullivan, D. (2010). On Reducing Cardiovascular Disease to a Rarity: Clinical Strategies and their Cost-Effectiveness. Heart, Lung and Circulation, 19(4), 225-227. [More Information]
  • Booth, M., Dobbins, T., Aitken, R., Denney-Wilson, E., Hardy, L., Okely, A., George, J., Sullivan, D., Cowell, C. (2009). Costs of managing conditions associated with obesity among Australian teenagers. Journal of Paediatrics and Child Health, 45(7-8), 448-456. [More Information]
  • Ayer, J., Sullivan, D., Sholler, G. (2009). Lipid abnormalities in children: should we be doing more? Medical Journal of Australia, 190(3), 107-108. [More Information]
  • Watts, G., Hamilton-Craig, I., Sullivan, D. (2009). NICE Guidance on Familial Hypercholesterolaemia: All Sugar and Spice? Heart, Lung and Circulation, 18(3), 181-183. [More Information]
  • Taskinen, M., Sullivan, D., Ehnholm, C., Whiting, M., Zannino, D., Simes, R., Keech, A., Barter, P. (2009). Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with Type 2 diabetes treated with fenofibrate. Arteriosclerosis, Thrombosis, and Vascular Biology, 29(6), 950-955. [More Information]
  • Kluger, E., Hardman, C., Govendir, M., Baral, R., Sullivan, D., Snow, D., Malik, R. (2009). Triglyceride response following an oral fat tolerance test in Burmese cats, other pedigree cats and domestic crossbred cats. Journal of Feline Medicine and Surgery, 11(2), 82-90. [More Information]
  • Wlodarzcyk, J., Smith, M., Sullivan, D. (2008). Assessment and Quantification of the Benefit Risk Ratio of Rosuvastatin and Atorvastatin from a Meta-Analysis of Head to Head Randomised Controlled Trials. Value in Health, 11(3), A188-A189.
  • Wlodarczyk, J., Sullivan, D., Smith, M. (2008). Comparison of benefits and risks of rosuvastatin versus atorvastatin from a meta-analysis of head-to-head randomized controlled trials. The American Journal of Cardiology, 102(12), 1654-1662. [More Information]
  • Tavakoli, N., Hambly, B., Sullivan, D., Bao, S. (2008). Forkhead box protein 3: Essential immune regulatory role. The International Journal of Biochemistry and Cell Biology, 40(11), 2369-2373. [More Information]
  • Homer, V., Marais, A., Charlton, F., Laurie, A., Hurndell, N., Scott, R., Mangili, F., Sullivan, D., Barter, P., Rye, K., et al (2008). Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa. Atherosclerosis, 196(2), 659-666. [More Information]
  • Lambert, G., Ancellin, N., Charlton, F., Comas, D., Pilot, J., Keech, A., Patel, S., Sullivan, D., Cohn, J., Rye, K., Barter, P. (2008). Plasma PCSK9 Concentrations Correlate with LDL and Total Cholesterol in Diabetic Patients and Are Decreased by Fenofibrate Treatment. Clinical Chemistry (Washington, DC), 54(6), 1038-1045. [More Information]
  • Tognarini, D., Sullivan, D., Thomas, D., Sikaris, K. (2008). Reducing CVD risk - integration of clinical and laboratory criteria. Australian Family Physician, 37(6), 422-427.
  • Jones, G., McNeil, A., Stewart, P., Sullivan, D., Vasikaran, S., Barker, A., DeVoss, K., Badrick, T., Chiu, W., Royal College of Pathologists of Australasia, (., et al (2008). Royal College of Pathologists of Australasia (RCPA) and Australasian Association of Clinical Biochemists (AACB) Position Statement on Impaired Fasting Glucose. Pathology, 40(6), 627-628.
  • Kluger, E., Malik, R., Ilkin, W., Snow, D., Sullivan, D., Govendir, M. (2008). Serum triglyceride concentration in dogs with epilepsy treated with phenobarbital or with phenobarbital and bromide. Journal of the American Veterinary Medical Association, 233(8), 1270-1277. [More Information]
  • Chow, C., Naidu, S., Raju, P., Raju, R., Joshi, R., Sullivan, D., Celermajer, D., Neal, B. (2008). Significant lipid, adiposity and metabolic abnormalities amongst 4535 Indians from a developing region of rural Andhra Pradesh. Atherosclerosis, 196, 943-952. [More Information]
  • Brown, A., Lattimore, J., McGrady, M., Sullivan, D., Dyer, W., Braet, F., Dos Remedios, C. (2008). Stable and unstable angina: Identifying novel markers on circulating leukocytes. Proteomics - Clinical Applications, 2, 90-98. [More Information]
  • West, M., Nestel, P., Kirby, A., Schnabel, R., Sullivan, D., Simes, R., Pollicino, C., Lubos, E., Munzel, T., White, H., et al (2008). The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study. European Heart Journal, 29(7), 923-931. [More Information]
  • Watts, G., Lewis, B., Sullivan, D. (2007). Familial hypercholesterolemia: a missed opportunity in preventive medicine. Nature Clinical Practice Cardiovascular Medicine, 4(8), 404-405. [More Information]
  • Tavakoli, N., Hambly, B., Sullivan, D., Bao, B. (2007). Forkhead box protein 3: Essential immune regulatory role. The International Journal of Biochemistry and Cell Biology, doi:10.1016/j.biocel.2007.10.004(40 (11)), 2369-2373. [More Information]
  • Emery, J., Barlow-Stewart, K., Metcalfe, S., Sullivan, D. (2007). Genetics and preventive health care. Australian Family Physician, 36(10), 808-11. [More Information]
  • Sullivan, D. (2007). Guidelines for the diagnosis and management of familial hypercholesterolaemia. Heart, Lung and Circulation, 16(1), 25-7. [More Information]
  • Homer, V., Marais, A., Laurie, A., Charlton, F., Sullivan, D., Barter, P., Rye, K., George, P., Lambert, G. (2007). Identification and Molecular Characterization of New PCSK9 Missense Mutations Associated with Familial Hypercholesterolemia. Arteriosclerosis, Thrombosis, and Vascular Biology, 27(6), e-122.
  • Sullivan, D., Thomas, D., Tognarini, D. (2007). Rationale for recommendations for lipid testing and reporting by Australian pathology laboratories. Clinical Biochemist Reviews, 28(2), 46-49. [More Information]
  • Appleton, C., Caldwell, G., McNeil, A., Meerkin, M., Sikaris, K., Sullivan, D., Thomas, D., Tognarini, D. (2007). Recommendations for lipid testing and reporting by Australian pathology laboratories. Clinical Biochemist Reviews, 28(2), 32-45. [More Information]
  • Skilton, M., Sieveking, D., Harmer, J., Franklin, J., Loughnan, G., Nakhla, S., Sullivan, D., Caterson, I., Celermajer, D. (2007). The effects of obesity and non-pharmacological weight loss on vascular and ventricular function and structure. Diabetes, Obesity and Metabolism, 10(10), 874-884. [More Information]
  • Al-Mahdili, H., Hooper, A., Sullivan, D., Stewart, P., Burnett, J. (2006). A mild case of abetalipoproteinaemia in association with subclinical hypothyroidism. Annals of Clinical Biochemistry: an international journal of biochemistry in medicine, 43, 516-519. [More Information]
  • Tapsell, L., Hemphill, I., Cobiac, L., Sullivan, D., Fenech, M., Patch, C., Keogh, J., Clifton, P., Williams, P., Inge, K. (2006). Health benefits of herbs and spices: the past, the present, the future. Medical Journal of Australia, 185(4), S4-S24. [More Information]
  • Cogger, V., Hilmer, S., Sullivan, D., Muller, M., Fraser, R., Le Couteur, D. (2006). Hyperlipidemia and surfactants: The liver sieve is a link. Atherosclerosis, 189, 273-281. [More Information]
  • Lau, G., Ridley, L., Bannon, P., Freedman, B., Brieger, D., Sullivan, D., Wong, L., Kritharides, L. (2006). Hypertriglyceridaemia is associated with early non-patency of coronary bypass grafts. Heart, 92(4), 536-538. [More Information]
  • Stocker, R., Pollicino, C., Gay, C., Nestel, P., Colquhoun, D., Whiting, M., Tonkin, A., Sullivan, D., Simes, R. (2006). Neither plasma coenzyme Q(10) concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: A prospective case-control study from the LIPID study. Atherosclerosis, 187(1), 198-204. [More Information]
  • Tulloh, L., Robinson, D., Patel, A., Ware, A., Prendergast, C., Sullivan, D., Pressley, L. (2006). Raised troponin T and echocardiographic abnormalities after prolonged strenuous exercise--the Australian Ironman Triathlon. British Journal of Sports Medicine, 40(7), 605-609. [More Information]
  • Abraham, N., Lemech, L., Sandroussi, C., Sullivan, D., May, J. (2005). A prospective study of subclinical myocardial damage in endovascular versus open repair of infrarenal abdominal aortic aneurysms. Journal Of Vascular Surgery, 41(3), 377-380. [More Information]
  • Hilmer, S., Cogger, V., Fraser, R., McLean, A., Sullivan, D., Le Couteur, D. (2005). Age-related changes in the hepatic sinusoidal endothelium impede lipoprotein transfer in the rat. Hepatology, 42(6), 1349-1354. [More Information]
  • Swinburn, B., Carey, D., Hills, A., Hooper, M., Marks, S., Proietto, J., Strauss, B., Sullivan, D., Welborn, T., Caterson, I. (2005). Effect of orlistat on cardiovascular disease risk in obese adults. Diabetes, Obesity and Metabolism, 7(3), 254-62. [More Information]
  • Keech, A., Simes, R., Barter, P., Best, J., Scott, R., Taskinen, M., Forder, P., Pillai, A., Davis, T., Glasziou, P., Sullivan, D., MacMahon, S., et al (2005). Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. The Lancet, 366(9500), 1849. [More Information]
  • Samra, J., Sved, P., Sullivan, D., Hugh, T., Smith, R. (2005). Lipid metabolism in omental adipose tissue during operative surgery. Journal of Surgical Research, 124(1), 23-28. [More Information]
  • Simons, L., Sullivan, D. (2005). Lipid-modifying drugs. Medical Journal of Australia, 182(6), 286-289. [More Information]
  • Skilton, M., Lai, N., Griffiths, K., Molyneaux, L., Yue, D., Sullivan, D., Celermajer, D. (2005). Meal-related increases in vascular reactivity are impaired in older and diabetic adults: insights into roles of aging and insulin in vascular flow. American Journal of Physiology: Heart and Circulatory Physiology, 288(3), H1404-H1410. [More Information]
  • Tonkin, A., Barter, P., Best, J., Boyden, A., Furler, J., Hossack, K., Sullivan, D., Thompson, P., Vale, M., Cooper, C., et al (2005). National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005. Heart, Lung and Circulation, 14(4), 275. [More Information]
  • Patel, A., Woodward, M., Campbell, D., Sullivan, D., Colman, S., Chalmers, J., Neal, B., MacMahon, S. (2005). Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease. European Heart Journal, 26(18), 1910-1915. [More Information]
  • Sullivan, D. (2005). The clinical and nutritional implications of lipid-lowering drugs that act in the gastrointestinal tract. Current Opinion in Lipidology, 16(1), 39-45. [More Information]
  • Sullivan, D., West, M., Jeremy, R. (2005). Utility of Brain Natriuretic Peptide (BNP) Measurement in Cardiovascular Disease. Heart, Lung and Circulation, 14(2), 78-84. [More Information]
  • Kockx, M., Rye, K., Gaus, K., Quinn, C., Wright, J., Sloane, T., Sviridov, D., Sullivan, D., Fu, Y., Burnett, J., Kritharides, L., et al (2004). Apolipoprotein A-I-Stimulated Apolipoprotein E Secretion From Human Macrophages Is Independent Of Cholesterol Efflux. Journal of Biological Chemistry, 279(25), 25966-25977.
  • Clifton, P., Noakes, M., Sullivan, D., Erichsen, N., Ross, D., Annison, G., Fassoulakis, A., Cehun, M., Nestel, P. (2004). Cholesterol-Lowering Effects Of Plant Sterol Esters Differ In Milk, Yoghurt, Bread And Cereal. European Journal of Clinical Nutrition, 58, 503-509.
  • Lau, G., Sullivan, D. (2004). Preoperative hypertriglyceridemia is associated with early occlusion of radial artery but not saphenous vein coronary bypass grafts. Circulation, 110, 183-184.
  • Hilmer, S., Warren, A., Cogger, V., Fraser, R., McLean, A., Sullivan, D., Le Couteur, D. (2004). The Effect Of Aging On The Immunohistochemistry Of Apolipoprotein E In The Liver. Experimental Gerontology, 39(1), 53-57.
  • Sullivan, D., Celermajer, D., Le Couteur, D., Lam, C. (2004). The Vascular Implications Of Postprandial Lipoprotein Metabolism. Clinical Biochemist Reviews, 25(1), 19-30.
  • Yen, T., Nightingale, B., Burns, J., Sullivan, D., Stewart, P. (2003). Butylcholinesterase (BCHE) Genotyping for post-succinylcholine apnea in an Australian population. Clinical Chemistry (Washington, DC), 49(8), 1297-1308.
  • Nugent, A., Leung, K., Sullivan, D., Reutens, A., Ho, K. (2003). Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women. Clinical Endocrinology, 59(6), 690-698.
  • Gatto, L., Sullivan, D., Samman, S. (2003). Postprandial effects of dietary trans fatty acids on apolipoprotein (a) and cholesterol ester transfer. American Journal of Clinical Nutrition, 77(5), 1119-1124.
  • Sullivan, D. (2003). Recent trends in lipid management: raising the bar and shifting the goalposts? Internal Medicine Journal, 33(3), 95-102.
  • Prasan, A., McCarron, H., Hambly, B., Fermanis, G., Sullivan, D., Jeremy, R. (2002). Effect of treatment on ventricular function and troponin I proteolysis in reperfused myocardium. Journal of Molecular and Cellular Cardiology, 34(4), 401-411. [More Information]
  • Simes, R., Marschner, C., Hunt, D., Sullivan, D., Colquhoun, D., Hague, W., Stewart, R., Keech, A., Thompson, P., White, H., et al (2002). Relationship between lipid levels and clinical outcomes in the long-term intervention with pravastatin in ischemic disease (LIPID) trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels? Circulation, 105(10), 1162-1169.
  • Raitakari, O., McCredie, R., Letters, J., Witting, P., Griffiths, K., Sullivan, D., Stocker, R., Celermajer, D. (2000). Coenzyme Q improves LDL resistance to ex vivo oxidation but does not enhance endothelial function in hypercholesterolemic young adults. Free Radical Biology and Medicine, 28, 1100-1105.
  • Mears, D., Chui, A., Stewart, P., Burns, J., Sullivan, D., Bowen, D., Sheil, A. (2000). Lecithin Cholesterol Acyltransferase Activity Following Orthotopic Liver Transplantation. Transplantation Proceedings, 32(1), 169-170.
  • Raitakari, O., Lai, N., Griffiths, K., McCredie, R., Sullivan, D., Celermajer, D. (2000). Preserved endothelial function and enhanced peripheral vasodilation in humans after a fatty meal. Journal of the American College of Cardiology, 36, 417-422.

Conferences

  • Sullivan, D., Forder, P., Simes, R., Whiting, M., Keech, A. (2006). Individual and combined effects of fenofibrate and sulphonylureas on HDL cholesterol and outcomes. XIV International Symposium on Atherosclerosis, Ireland: Elsevier Ireland Ltd.
  • May, J., Abraham, N., Sullivan, D., White, G., Harris, J. (2006). Previously underestimated incidence of subclinical myocardial damage: A prospective concurrent comparison of endovascular versus open repair of infrarenal AAA. 19th International Congress on Endovascular Interventions, United states: Alliance Communication Group.
  • Caterson, I., Carey, D., Hills, A., Hooper, M., Marks, S., Proietto, J., Strauss, B., Sullivan, D., Swinburn, B., Welborn, T. (2001). The Australasian Orlistat Multi-Comorbidity Study. 10th Meeting of the Australasian Society for the Study of Obesity, : Ads & Adea.

2014

  • Stroes, E., Colquhoun, D., Sullivan, D., Civeira, F., Rosenson, R., Watts, G., Bruckert, E., Cho, L., Dent, R., Knusel, B., et al (2014). Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients with Statin Intolerance: The GAUSS-2 Randomized, Placebo-controlled Phase 3 Clinical Trial of Evolocumab. Journal of the American College of Cardiology, 63(23), 2541-2548. [More Information]
  • White, H., Tonkin, A., Simes, R., Stewart, R., Mann, K., Thompson, P., Colquhoun, D., West, M., Nestel, P., Sullivan, D., Keech, A., et al (2014). Association of Contemporary Sensitive Troponin I Levels at Baseline and Change at 1 Year With Long - Term Coronary Events Following Myocardial Infarction or Unstable Angina. Journal of the American College of Cardiology, 63(4), 345-354. [More Information]
  • Cho, L., Rocco, M., Colquhoun, D., Sullivan, D., Rosenson, R., Dent, R., Xue, A., Scott, R., Wasserman, S., Stroes, E. (2014). Design and rationale of the GAUSS-2 study trial: a double-blind, ezetimibe-controlled phase 3 study of the efficacy and tolerability of evolocumab (AMG 145) in subjects with hypercholesterolemia who are intolerant of statin therapy. Clinical cardiology, 37(3), 131-139. [More Information]
  • Hinchcliffe, M., Le, H., Fimmel, A., Molloy, L., Freeman, L., Sullivan, D., Trent, R. (2014). Diagnostic validation of a familial hypercholesterolaemia cohort provides a model for using targeted next generation DNA sequencing in the clinical setting. Pathology, 46(1), 60-68. [More Information]
  • Watts, G., Gidding, S., Wierzbicki, A., Toth, P., Rodrigo, A., Brown, W., Bruckert, E., Defesche, J., Lin, K., Livingston, M., Sullivan, D., et al (2014). Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. International Journal of Cardiology, 171(3), 309-325. [More Information]
  • Watts, G., Gidding, S., Wierzbicki, A., Toth, P., Alonso, R., Brown, W., Bruckert, E., Defesche, J., Lin, K., Livingston, M., Sullivan, D., et al (2014). Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation. Journal of Clinical Lipidology, 8(2), 148-172. [More Information]

2013

  • White, H., Simes, R., Stewart, R., Blankenberg, S., Barnes, E., Marschner, C., Thompson, P., West, M., Zeller, T., Colquhoun, D., Keech, A., Sullivan, D., et al (2013). Changes in lipoprotein-associated phospholipase A2 activity predict coronary events and partly account for the treatment effect of pravastatin: results from the Long-Term Intervention with Pravastatin in Ischemic Disease study. Journal of the American Heart Association, 2(5), 1-12. [More Information]
  • Hoyos, C., Sullivan, D., Liu, P. (2013). Effect of CPAP on the metabolic syndrome: a randomised sham-controlled study. Thorax, 68(6), 588-589. [More Information]
  • Martin, A., Coakley, J., Forbes, D., Sullivan, D., Watts, G. (2013). Familial hypercholesterolaemia in children and adolescents: A new paediatric model of care. Journal of Paediatrics and Child Health, 49(4), E263-E272. [More Information]
  • Boekholdt, S., Arsenault, B., Hovingh, G., Mora, S., Pedersen, T., LaRosa, J., Welch, K., Amarenco, P., DeMicco, D., Tonkin, A., Sullivan, D., Kirby, A., et al (2013). Levels and Changes of HDL Cholesterol and Apolipoprotein A-I in Relation to Risk of Cardiovascular Events Among Statin-Treated Patients: A Meta-Analysis. Circulation, 128(14), 1504-1512. [More Information]
  • Nestel, P., Barnes, E., Tonkin, A., Simes, R., Fournier, M., White, H., Colquhoun, D., Blankenberg, S., Sullivan, D. (2013). Plasma Lipoprotein(a) Concentration Predicts Future Coronary and Cardiovascular Events in Patients With Stable Coronary Heart Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 33(12), 2902-2908. [More Information]
  • Chan, K., O'Connell, R., Sullivan, D., Hoffmann, L., Rajamani, K., Whiting, M., Donoghoe, M., Vanhala, M., Hamer, A., Yu, B., Stocker, R., Ng, M., Keech, A. (2013). Plasma total bilirubin levels predict amputation events in type 2 diabetes mellitus: the fenofibrate intervention and event lowering in diabetes (field) study. Diabetologia: clinical and experimental diabetes and metabolism, 56(4), 724-736. [More Information]
  • Hankey, G., Anderson, N., Ting, R., Veillard, A., Romo, M., Wosik, M., Sullivan, D., O'Connell, R., Hunt, D., Keech, A. (2013). Rates and predictors of risk of stroke and its subtypes in diabetes: A prospective observational study. Journal of Neurology, Neurosurgery and Psychiatry, 84(3), 281-287. [More Information]
  • Lewis, B., Sullivan, D., Watts, G. (2013). Thought for food: Clinical evidence for the dietary prevention strategy in cardiovascular disease. International Journal of Evidence-Based Healthcare (online), 11(4), 330-336. [More Information]

2012

  • Watts, G., Sullivan, D., van Bockxmeer, F., Poplawski, N., Hamilton-Craig, I., Clifton, P., O'Brien, R., Bishop, W., George, P., Semsarian, C., et al (2012). A New Model of Care for Familial Hypercholesterolaemia: What is the Role of Cardiology? Heart, Lung and Circulation, 21(9), 543-550. [More Information]
  • McEwen, B., Phillips, C., Morel-Kopp, M., Yee, B., Sullivan, D., Ward, C., Tofler, G., Grunstein, R. (2012). Diurnal changes and levels of fibrin generation are not altered by continuous positive airway pressure (CPAP) in obstructive sleep apnoea (OSA). Journal of Thrombosis and Haemostasis, 108(4), 701-709. [More Information]
  • Sullivan, D., Olsson, A., Scott, R., Kim, J., Xue, A., Gebski, V., Wasserman, S., Stein, E. (2012). Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial. JAMA, 308(23), 2497-2506. [More Information]
  • Phillips, C., McEwen, B., Morel-Kopp, M., Yee, B., Sullivan, D., Ward, C., Tofler, G., Grunstein, R. (2012). Effects of continuous positive airway pressure on coagulability in obstructive sleep apnoea: a randomised, placebo-controlled crossover study. Thorax, 67(7), 639-644. [More Information]
  • Nik Tavakoli, N., Harris, A., Sullivan, D., Hambly, B., Bao, B. (2012). Interferon-g deficiency reduces neointimal formation in a model of endoluminal endothelial injury combined with atherogenic diet. International Journal of Molecular Medicine, 30(3), 545-552. [More Information]
  • Sullivan, D., Hamilton-Craig, I., van Bockxmeer, F., Watts, G. (2012). INTERIM Guidelines for the Diagnosis and Management of Familial Hypercholesterolaemia. Heart, Lung and Circulation, 21(3), 159-162. [More Information]
  • Ong, K., Rye, K., O'Connell, R., Jenkins, A., Brown, C., Xu, A., Sullivan, D., Barter, P., Keech, A. (2012). Long-Term Fenofibrate Therapy Increases Fibroblast Growth Factor 21 and Retinol-Binding Protein 4 in Subjects with Type 2 Diabetes. Journal of Clinical Endocrinology and Metabolism, 97(12), 4701-4708. [More Information]
  • Kotwal, S., Jun, M., Sullivan, D., Perkovic, V., Neal, B. (2012). Omega 3 Fatty Acids and Cardiovascular Outcomes: Systematic Review and Meta-Analysis. Circulation. Cardiovascular Quality and Outcomes, 5(6), 808-818. [More Information]
  • Herrmann, M., Whiting, M., Veillard, A., Ehnholm, C., Sullivan, D., Keech, A. (2012). Plasma homocysteine and the risk of venous thromboembolism: Insights from the FIELD study. Clinical Chemistry and Laboratory Medicine, 50(12), 2213-2219. [More Information]

2011

  • Sullivan, D., Lewis, B. (2011). A classification of lipoprotein disorders: Implications for clinical management. Clinical Lipidology, 6(3), 327-338.
  • Sullivan, D., Forder, P., Simes, R., Whiting, M., Kritharides, L., Merrifield, A., Donoghoe, M., Colman, P., Neil, G., Haapamäki, H., Keech, A. (2011). Associations between the use of metformin, sulphonylureas, or diet alone and cardiovascular outcomes in 6005 patients with type 2 diabetes in the FIELD study. Diabetes Research and Clinical Practice, 94(2), 284-290. [More Information]
  • Phillips, C., Yee, B., Marshall, N., Liu, P., Sullivan, D., Grunstein, R. (2011). Continuous Positive Airway Pressure Reduces Postprandial Lipidemia in Obstructive Sleep Apnea. A Randomised, Placebo Controlled Crossover Trial. American Journal of Respiratory and Critical Care Medicine, 184(3), 355-361. [More Information]
  • Watts, G., Sullivan, D., Poplawski, N., van Bockxmeer, F., Hamilton-Craig, I., Clifton, P., O'Brien, R., Bishop, W., George, P., Barter, P., Freeman, L., Krass, I., Trent, R., et al (2011). Familial hypercholesterolaemia: A model of care for Australasia. Atherosclerosis Supplements, 12, 221-263. [More Information]
  • Perera, N., Lewis, B., Tran, H., Fietz, M., Sullivan, D. (2011). Refsum's Disease-Use of the Intestinal Lipase Inhibitor, Orlistat, as a Novel Therapeutic Approach to a Complex Disorder. Journal of Obesity, 2011 (482021). [More Information]

2010

  • Simes, R., Voysey, M., O'Connell, R., Glasziou, P., Best, J., Scott, R., Pardy, C., Byth Wilson, K., Sullivan, D., Ehnholm, C., Keech, A. (2010). A novel method to adjust efficacy estimates for uptake of other active treatments in long-term clinical trials. PLoS One, 5(1), e8580-1-e8580-10. [More Information]
  • Taskinen, M., Barter, P., Ehnholm, C., Sullivan, D., Mann, K., Simes, R., Best, J., Hamwood, S., Keech, A. (2010). Ability of traditional lipid ratios and apolipoprotein ratios to predict cardiovascular risk in people with type 2 diabetes. Diabetologia: clinical and experimental diabetes and metabolism, 53(9), 1846-1855. [More Information]
  • Perera, N., Burns, J., Perera, R., Lewis, B., Sullivan, D. (2010). Adjustment of direct high-density lipoprotein cholesterol measurements according to intercurrent triglyceride corrects for interference by triglyceride-rich lipoproteins. Journal of Clinical Lipidology, 4(4), 305-309. [More Information]
  • Al-Sarraf, A., Al-Ghofaili, K., Sullivan, D., Wasan, K., Hegele, R., Frohlich, J. (2010). Complete Apo AI deficiency in an Iraqi Mandaean family: case studies and review of the literature. Journal of Clinical Lipidology, 4(5), 420-426. [More Information]
  • Arya, F., Egger, S., Colquhoun, D., Sullivan, D., Pal, S., Egger, G. (2010). Differences in postprandial inflammatory responses to a 'modern' v. traditional meat meal: a preliminary study. British Journal of Nutrition, 104(5), 724-728. [More Information]
  • Webster, R., Webster, R., Li, S., Li, S., Sullivan, D., Sullivan, D., Su, S., Su, S., Jayne, K., Jayne, K., Neal, B., Neal, B. (2010). Effects Of Internet-Based Tailored Advice on the Use of Cholesterol-Lowering Interventions: A Randomized Controlled Trial. Journal of Medical Internet Research, 12(3), 1-13. [More Information]
  • Puranik, R., Puranik, R., Fox, O., Fox, O., Sullivan, D., Sullivan, D., Duflou, J., Duflou, J., Bao, B., Bao, B. (2010). Inflammatory characteristics of premature coronary artery disease. International Journal of Cardiology, 145(2), 288-290. [More Information]
  • Lewis, B., Watts, G., Sullivan, D. (2010). On Reducing Cardiovascular Disease to a Rarity: Clinical Strategies and their Cost-Effectiveness. Heart, Lung and Circulation, 19(4), 225-227. [More Information]

2009

  • Booth, M., Dobbins, T., Aitken, R., Denney-Wilson, E., Hardy, L., Okely, A., George, J., Sullivan, D., Cowell, C. (2009). Costs of managing conditions associated with obesity among Australian teenagers. Journal of Paediatrics and Child Health, 45(7-8), 448-456. [More Information]
  • Ayer, J., Sullivan, D., Sholler, G. (2009). Lipid abnormalities in children: should we be doing more? Medical Journal of Australia, 190(3), 107-108. [More Information]
  • Watts, G., Hamilton-Craig, I., Sullivan, D. (2009). NICE Guidance on Familial Hypercholesterolaemia: All Sugar and Spice? Heart, Lung and Circulation, 18(3), 181-183. [More Information]
  • Taskinen, M., Sullivan, D., Ehnholm, C., Whiting, M., Zannino, D., Simes, R., Keech, A., Barter, P. (2009). Relationships of HDL cholesterol, ApoA-I, and ApoA-II with homocysteine and creatinine in patients with Type 2 diabetes treated with fenofibrate. Arteriosclerosis, Thrombosis, and Vascular Biology, 29(6), 950-955. [More Information]
  • Kluger, E., Hardman, C., Govendir, M., Baral, R., Sullivan, D., Snow, D., Malik, R. (2009). Triglyceride response following an oral fat tolerance test in Burmese cats, other pedigree cats and domestic crossbred cats. Journal of Feline Medicine and Surgery, 11(2), 82-90. [More Information]

2008

  • Wlodarzcyk, J., Smith, M., Sullivan, D. (2008). Assessment and Quantification of the Benefit Risk Ratio of Rosuvastatin and Atorvastatin from a Meta-Analysis of Head to Head Randomised Controlled Trials. Value in Health, 11(3), A188-A189.
  • Wlodarczyk, J., Sullivan, D., Smith, M. (2008). Comparison of benefits and risks of rosuvastatin versus atorvastatin from a meta-analysis of head-to-head randomized controlled trials. The American Journal of Cardiology, 102(12), 1654-1662. [More Information]
  • Tavakoli, N., Hambly, B., Sullivan, D., Bao, S. (2008). Forkhead box protein 3: Essential immune regulatory role. The International Journal of Biochemistry and Cell Biology, 40(11), 2369-2373. [More Information]
  • Homer, V., Marais, A., Charlton, F., Laurie, A., Hurndell, N., Scott, R., Mangili, F., Sullivan, D., Barter, P., Rye, K., et al (2008). Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa. Atherosclerosis, 196(2), 659-666. [More Information]
  • Lambert, G., Ancellin, N., Charlton, F., Comas, D., Pilot, J., Keech, A., Patel, S., Sullivan, D., Cohn, J., Rye, K., Barter, P. (2008). Plasma PCSK9 Concentrations Correlate with LDL and Total Cholesterol in Diabetic Patients and Are Decreased by Fenofibrate Treatment. Clinical Chemistry (Washington, DC), 54(6), 1038-1045. [More Information]
  • Tognarini, D., Sullivan, D., Thomas, D., Sikaris, K. (2008). Reducing CVD risk - integration of clinical and laboratory criteria. Australian Family Physician, 37(6), 422-427.
  • Jones, G., McNeil, A., Stewart, P., Sullivan, D., Vasikaran, S., Barker, A., DeVoss, K., Badrick, T., Chiu, W., Royal College of Pathologists of Australasia, (., et al (2008). Royal College of Pathologists of Australasia (RCPA) and Australasian Association of Clinical Biochemists (AACB) Position Statement on Impaired Fasting Glucose. Pathology, 40(6), 627-628.
  • Kluger, E., Malik, R., Ilkin, W., Snow, D., Sullivan, D., Govendir, M. (2008). Serum triglyceride concentration in dogs with epilepsy treated with phenobarbital or with phenobarbital and bromide. Journal of the American Veterinary Medical Association, 233(8), 1270-1277. [More Information]
  • Chow, C., Naidu, S., Raju, P., Raju, R., Joshi, R., Sullivan, D., Celermajer, D., Neal, B. (2008). Significant lipid, adiposity and metabolic abnormalities amongst 4535 Indians from a developing region of rural Andhra Pradesh. Atherosclerosis, 196, 943-952. [More Information]
  • Brown, A., Lattimore, J., McGrady, M., Sullivan, D., Dyer, W., Braet, F., Dos Remedios, C. (2008). Stable and unstable angina: Identifying novel markers on circulating leukocytes. Proteomics - Clinical Applications, 2, 90-98. [More Information]
  • West, M., Nestel, P., Kirby, A., Schnabel, R., Sullivan, D., Simes, R., Pollicino, C., Lubos, E., Munzel, T., White, H., et al (2008). The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study. European Heart Journal, 29(7), 923-931. [More Information]

2007

  • Watts, G., Lewis, B., Sullivan, D. (2007). Familial hypercholesterolemia: a missed opportunity in preventive medicine. Nature Clinical Practice Cardiovascular Medicine, 4(8), 404-405. [More Information]
  • Tavakoli, N., Hambly, B., Sullivan, D., Bao, B. (2007). Forkhead box protein 3: Essential immune regulatory role. The International Journal of Biochemistry and Cell Biology, doi:10.1016/j.biocel.2007.10.004(40 (11)), 2369-2373. [More Information]
  • Emery, J., Barlow-Stewart, K., Metcalfe, S., Sullivan, D. (2007). Genetics and preventive health care. Australian Family Physician, 36(10), 808-11. [More Information]
  • Sullivan, D. (2007). Guidelines for the diagnosis and management of familial hypercholesterolaemia. Heart, Lung and Circulation, 16(1), 25-7. [More Information]
  • Homer, V., Marais, A., Laurie, A., Charlton, F., Sullivan, D., Barter, P., Rye, K., George, P., Lambert, G. (2007). Identification and Molecular Characterization of New PCSK9 Missense Mutations Associated with Familial Hypercholesterolemia. Arteriosclerosis, Thrombosis, and Vascular Biology, 27(6), e-122.
  • Sullivan, D., Thomas, D., Tognarini, D. (2007). Rationale for recommendations for lipid testing and reporting by Australian pathology laboratories. Clinical Biochemist Reviews, 28(2), 46-49. [More Information]
  • Appleton, C., Caldwell, G., McNeil, A., Meerkin, M., Sikaris, K., Sullivan, D., Thomas, D., Tognarini, D. (2007). Recommendations for lipid testing and reporting by Australian pathology laboratories. Clinical Biochemist Reviews, 28(2), 32-45. [More Information]
  • Skilton, M., Sieveking, D., Harmer, J., Franklin, J., Loughnan, G., Nakhla, S., Sullivan, D., Caterson, I., Celermajer, D. (2007). The effects of obesity and non-pharmacological weight loss on vascular and ventricular function and structure. Diabetes, Obesity and Metabolism, 10(10), 874-884. [More Information]

2006

  • Al-Mahdili, H., Hooper, A., Sullivan, D., Stewart, P., Burnett, J. (2006). A mild case of abetalipoproteinaemia in association with subclinical hypothyroidism. Annals of Clinical Biochemistry: an international journal of biochemistry in medicine, 43, 516-519. [More Information]
  • Le Couteur, D., Cogger, V., Hilmer, S., Muller, M., Harris, M., Sullivan, D., McLean, A., Fraser, R. (2006). Aging, atheroscleroisis and the liver sieve. In Clarke, Leon V (Eds.), New research on atherosclerosis, (pp. 19-44). New York: Nova Science Publishers.
  • Field, M., Burnett, L., Sullivan, D., Stewart, P. (2006). Clinical biochemistry and metabolism. In NA Boon, NR Colledge, BR Walker, JAA Hunter (Eds.), Davidson's Principles & Practice of Medicine, (pp. 419-454). Edinburgh: Churchill Livingstone.
  • Tapsell, L., Hemphill, I., Cobiac, L., Sullivan, D., Fenech, M., Patch, C., Keogh, J., Clifton, P., Williams, P., Inge, K. (2006). Health benefits of herbs and spices: the past, the present, the future. Medical Journal of Australia, 185(4), S4-S24. [More Information]
  • Cogger, V., Hilmer, S., Sullivan, D., Muller, M., Fraser, R., Le Couteur, D. (2006). Hyperlipidemia and surfactants: The liver sieve is a link. Atherosclerosis, 189, 273-281. [More Information]
  • Lau, G., Ridley, L., Bannon, P., Freedman, B., Brieger, D., Sullivan, D., Wong, L., Kritharides, L. (2006). Hypertriglyceridaemia is associated with early non-patency of coronary bypass grafts. Heart, 92(4), 536-538. [More Information]
  • Sullivan, D., Forder, P., Simes, R., Whiting, M., Keech, A. (2006). Individual and combined effects of fenofibrate and sulphonylureas on HDL cholesterol and outcomes. XIV International Symposium on Atherosclerosis, Ireland: Elsevier Ireland Ltd.
  • Stocker, R., Pollicino, C., Gay, C., Nestel, P., Colquhoun, D., Whiting, M., Tonkin, A., Sullivan, D., Simes, R. (2006). Neither plasma coenzyme Q(10) concentration, nor its decline during pravastatin therapy, is linked to recurrent cardiovascular disease events: A prospective case-control study from the LIPID study. Atherosclerosis, 187(1), 198-204. [More Information]
  • May, J., Abraham, N., Sullivan, D., White, G., Harris, J. (2006). Previously underestimated incidence of subclinical myocardial damage: A prospective concurrent comparison of endovascular versus open repair of infrarenal AAA. 19th International Congress on Endovascular Interventions, United states: Alliance Communication Group.
  • Tulloh, L., Robinson, D., Patel, A., Ware, A., Prendergast, C., Sullivan, D., Pressley, L. (2006). Raised troponin T and echocardiographic abnormalities after prolonged strenuous exercise--the Australian Ironman Triathlon. British Journal of Sports Medicine, 40(7), 605-609. [More Information]

2005

  • Abraham, N., Lemech, L., Sandroussi, C., Sullivan, D., May, J. (2005). A prospective study of subclinical myocardial damage in endovascular versus open repair of infrarenal abdominal aortic aneurysms. Journal Of Vascular Surgery, 41(3), 377-380. [More Information]
  • Hilmer, S., Cogger, V., Fraser, R., McLean, A., Sullivan, D., Le Couteur, D. (2005). Age-related changes in the hepatic sinusoidal endothelium impede lipoprotein transfer in the rat. Hepatology, 42(6), 1349-1354. [More Information]
  • Field, M., Burnett, L., Sullivan, D., Stewart, P. (2005). Biochemical Disorders. In N Boon, N Colledge, B Walker, J Hunter (Eds.), Davidson's Principles and Practice of Medicine (20 Ed.), (pp. 1-2). United Kingdom: Elsevier.
  • Field, M., Burnett, L., Sullivan, D., Stewart, P. (2005). Clinical biochemistry and metabolism. In Nicholas A. Boon, Nicki R. Colledge, Brian R. Walker and John Hunter (Eds.), Davidson's Principles and Practice of Medicine, (pp. 419-454). Churchill Livingstone.
  • Swinburn, B., Carey, D., Hills, A., Hooper, M., Marks, S., Proietto, J., Strauss, B., Sullivan, D., Welborn, T., Caterson, I. (2005). Effect of orlistat on cardiovascular disease risk in obese adults. Diabetes, Obesity and Metabolism, 7(3), 254-62. [More Information]
  • Keech, A., Simes, R., Barter, P., Best, J., Scott, R., Taskinen, M., Forder, P., Pillai, A., Davis, T., Glasziou, P., Sullivan, D., MacMahon, S., et al (2005). Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. The Lancet, 366(9500), 1849. [More Information]
  • Samra, J., Sved, P., Sullivan, D., Hugh, T., Smith, R. (2005). Lipid metabolism in omental adipose tissue during operative surgery. Journal of Surgical Research, 124(1), 23-28. [More Information]
  • Simons, L., Sullivan, D. (2005). Lipid-modifying drugs. Medical Journal of Australia, 182(6), 286-289. [More Information]
  • Skilton, M., Lai, N., Griffiths, K., Molyneaux, L., Yue, D., Sullivan, D., Celermajer, D. (2005). Meal-related increases in vascular reactivity are impaired in older and diabetic adults: insights into roles of aging and insulin in vascular flow. American Journal of Physiology: Heart and Circulatory Physiology, 288(3), H1404-H1410. [More Information]
  • Tonkin, A., Barter, P., Best, J., Boyden, A., Furler, J., Hossack, K., Sullivan, D., Thompson, P., Vale, M., Cooper, C., et al (2005). National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand: position statement on lipid management--2005. Heart, Lung and Circulation, 14(4), 275. [More Information]
  • Patel, A., Woodward, M., Campbell, D., Sullivan, D., Colman, S., Chalmers, J., Neal, B., MacMahon, S. (2005). Plasma lipids predict myocardial infarction, but not stroke, in patients with established cerebrovascular disease. European Heart Journal, 26(18), 1910-1915. [More Information]
  • Sullivan, D. (2005). The clinical and nutritional implications of lipid-lowering drugs that act in the gastrointestinal tract. Current Opinion in Lipidology, 16(1), 39-45. [More Information]
  • Sullivan, D., West, M., Jeremy, R. (2005). Utility of Brain Natriuretic Peptide (BNP) Measurement in Cardiovascular Disease. Heart, Lung and Circulation, 14(2), 78-84. [More Information]

2004

  • Kockx, M., Rye, K., Gaus, K., Quinn, C., Wright, J., Sloane, T., Sviridov, D., Sullivan, D., Fu, Y., Burnett, J., Kritharides, L., et al (2004). Apolipoprotein A-I-Stimulated Apolipoprotein E Secretion From Human Macrophages Is Independent Of Cholesterol Efflux. Journal of Biological Chemistry, 279(25), 25966-25977.
  • Clifton, P., Noakes, M., Sullivan, D., Erichsen, N., Ross, D., Annison, G., Fassoulakis, A., Cehun, M., Nestel, P. (2004). Cholesterol-Lowering Effects Of Plant Sterol Esters Differ In Milk, Yoghurt, Bread And Cereal. European Journal of Clinical Nutrition, 58, 503-509.
  • Lai, N., Lyons-Wall, P., Samman, S., Sullivan, D. (2004). Intake of Selected Phytochemicals and Prevention of Coronary Heart Disease: Practical Implications. In R. Nath, M. Khullar and P. Singal (Eds.), Antioxidants and Cardiovascular Disease, (pp. 194-202). New Delhi, India: Narosa Publishing House.
  • Lau, G., Sullivan, D. (2004). Preoperative hypertriglyceridemia is associated with early occlusion of radial artery but not saphenous vein coronary bypass grafts. Circulation, 110, 183-184.
  • Hilmer, S., Warren, A., Cogger, V., Fraser, R., McLean, A., Sullivan, D., Le Couteur, D. (2004). The Effect Of Aging On The Immunohistochemistry Of Apolipoprotein E In The Liver. Experimental Gerontology, 39(1), 53-57.
  • Sullivan, D., Celermajer, D., Le Couteur, D., Lam, C. (2004). The Vascular Implications Of Postprandial Lipoprotein Metabolism. Clinical Biochemist Reviews, 25(1), 19-30.

2003

  • Yen, T., Nightingale, B., Burns, J., Sullivan, D., Stewart, P. (2003). Butylcholinesterase (BCHE) Genotyping for post-succinylcholine apnea in an Australian population. Clinical Chemistry (Washington, DC), 49(8), 1297-1308.
  • Nugent, A., Leung, K., Sullivan, D., Reutens, A., Ho, K. (2003). Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women. Clinical Endocrinology, 59(6), 690-698.
  • Gatto, L., Sullivan, D., Samman, S. (2003). Postprandial effects of dietary trans fatty acids on apolipoprotein (a) and cholesterol ester transfer. American Journal of Clinical Nutrition, 77(5), 1119-1124.
  • Sullivan, D. (2003). Recent trends in lipid management: raising the bar and shifting the goalposts? Internal Medicine Journal, 33(3), 95-102.

2002

  • Prasan, A., McCarron, H., Hambly, B., Fermanis, G., Sullivan, D., Jeremy, R. (2002). Effect of treatment on ventricular function and troponin I proteolysis in reperfused myocardium. Journal of Molecular and Cellular Cardiology, 34(4), 401-411. [More Information]
  • Simes, R., Marschner, C., Hunt, D., Sullivan, D., Colquhoun, D., Hague, W., Stewart, R., Keech, A., Thompson, P., White, H., et al (2002). Relationship between lipid levels and clinical outcomes in the long-term intervention with pravastatin in ischemic disease (LIPID) trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels? Circulation, 105(10), 1162-1169.

2001

  • Caterson, I., Carey, D., Hills, A., Hooper, M., Marks, S., Proietto, J., Strauss, B., Sullivan, D., Swinburn, B., Welborn, T. (2001). The Australasian Orlistat Multi-Comorbidity Study. 10th Meeting of the Australasian Society for the Study of Obesity, : Ads & Adea.

2000

  • Raitakari, O., McCredie, R., Letters, J., Witting, P., Griffiths, K., Sullivan, D., Stocker, R., Celermajer, D. (2000). Coenzyme Q improves LDL resistance to ex vivo oxidation but does not enhance endothelial function in hypercholesterolemic young adults. Free Radical Biology and Medicine, 28, 1100-1105.
  • Mears, D., Chui, A., Stewart, P., Burns, J., Sullivan, D., Bowen, D., Sheil, A. (2000). Lecithin Cholesterol Acyltransferase Activity Following Orthotopic Liver Transplantation. Transplantation Proceedings, 32(1), 169-170.
  • Raitakari, O., Lai, N., Griffiths, K., McCredie, R., Sullivan, D., Celermajer, D. (2000). Preserved endothelial function and enhanced peripheral vasodilation in humans after a fatty meal. Journal of the American College of Cardiology, 36, 417-422.

To update your profile click here. For support on your academic profile contact .